Home » Reports » Broker Ratings » GlaxoSmithKline plc 11.1% Potential Upside Indicated by UBS

GlaxoSmithKline plc 11.1% Potential Upside Indicated by UBS

GlaxoSmithKline plc with EPIC/TICKER (LON:GSK) had its stock rating noted as ‘Upgrades’ with the recommendation being set at ‘BUY’ today by analysts at UBS. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. UBS have set a target price of 1900 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 11.1% from the opening price of 1709.6 GBX. Over the last 30 and 90 trading days the company share price has increased 54.4 points and increased 17 points respectively. The 52 week high share price is 1796.4 GBX while the year low share price is currently 1408.8 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,713.94 GBX and a 200 day moving average of 1,633.38. There are currently 4,988,916,711 shares in issue with the average daily volume traded being 8,373,074. Market capitalisation for LON:GSK is £85,090,962,204 GBP.